1 / 39

Nephrology presentation 28/3/2011

Nephrology presentation 28/3/2011. History. 62 year male from Bethlehem referred with renal failure 1/12 ago: Constitutional complaints No clear focus of infection Raised CRP and lymphopenia Normal renal function

abner
Download Presentation

Nephrology presentation 28/3/2011

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Nephrology presentation28/3/2011

  2. History

  3. 62 year male from Bethlehem referred with renal failure • 1/12 ago: Constitutional complaints No clear focus of infection Raised CRP and lymphopenia Normal renal function • He was treated symptomatically and discharged

  4. However, one month later, his symptoms had not improved • On systemic enquiry - fleeting arthralgia of the large joints - myalgia of the arms and thighs with initiation of movement - he denied any ENT symptoms or skin rash - 35 pack year smoking history, diagnosed with emphysema, but never had any episodes of acute bronchospasm

  5. Occupation: administrative work, some occasional welding • No previous history of note, i.e. hypertension, DM • No nephrotoxic drugs

  6. Clinical examination

  7. Vitals: BP 105/70, pulse 80/min • Gen: pale with no edema • CVS: loud P2 • Resp: hyperinflated with good bilateral air entry • Abdo: normal • CNS: normal • ENT: reddish uvula, no ulcers • Skin: no evidence of vasculitis / connective tissue disease

  8. Special investigations

  9. Urine • Urine dipstix: 3+ hematuria, 2+ proteinuria • Microscopy: active sediment • MCS: no evidence of infection • 24 hour collection: dU protein 0.5g

  10. Blood investigations • FBC: Hb 8,4 / MCV 88 • U+E: urea 11,6 creatinine 299 • CRP 69 • ESR >90 • HIV (-) • Hepatitis B and C (-) • Protein electrophoresis normal • Complement normal • ANA (-) • cANCA (proteinase 3) > 100, pANCA (MPO) - negative • Anti-GBM - pending

  11. Radiology • Renal ultrasound showed normal sized kidneys • CXR: hyperinflation, but clear • Shoulder x-ray: evidence of OA

  12. Histology • Segmental necrotizing vaculitis • Few crescents • No granuloma formation • No eosinophillic infiltrates • No immune complexes

  13. Small cell vasculitis and the kidney

  14. Vasculitis is a clinicopathological process characterized by inflammation of and damage to the blood vessels • Affected vessels vary in size, type and location • Can occur as result of a primary process or secondary to another underlying disease • Given the numerous and varied types of vessels in the kidneys, renal disease is caused by a variety of systemic vasculitides.

  15. Vasculitis Large sized vessels Small sized vessels • Takayasu’s - ANCA (+) • Giant cell arteritis - ANCA (-) Medium-sized vessels - Poly-arteritis nodosa - Kawasaki’s disease

  16. Small vessel vasculitis ANCA (+) ANCA (-) HenlochShönleinpurpura Cryglobulinemic Connective tissue disorders Goodpasture’s disease Infection induced Hypersensitivity Paraneoplastic • Wegener’s granulomatosis • Microscopic poliangiitis • Renal limited vasculitis / ANCA GN • Churg Strauss syndrome • Drug induced

  17. Anca (+)

  18. Wegener’s granulomatosis • 5-10 / 1 000 000 • Granulomatous inflammation and necrotizing vasculitis affecting the nasal passages, airways and kidneys. • Common presentation include upper airway involvement – epistaxis, nasal crusting, hemoptysis, ulceration and deafness secondary to serious otitis media. • Inflammation of the retro-orbital tissue van cause proptosis and optic nerve compression • Untreated nasal discharge leads to bone and cartilage destruction • Migratory pulmonary inflitrates and nodules on CXR • Mostly cANCA(proteinase 3)

  19. Microscopic poliangiitis • 8 / 1 000 000 • Necrotizing vasculitis affecting the capillaries, venules or arterioles • Typically presentation includes a rapidly progressive GN, often associated with alveolar haemorrhage • Cutaneous and GIT involvement • pANCA (+), but can be cANCA (+) • Considered as part of a clinical spectrum that includes Wegener’s and renal limited vasculitis

  20. Renal limited vasculitis • Part of the spectrum including Wegener’s and microscopic poly-angiitis • No systemic involvement • Histology: necrotizing GN

  21. The spectrum • Renal limited vasculitis - vasculitis with necrotizing GN - no systemic symptoms • Microscopic polyangiitis - vasculitis with necrotizing GN - systemic symptoms and involvement • Wegener’s granulomatosis - vasculitis with necrotizing GN - granuloma formation - systemic symptoms and involvement

  22. Churgstrauss syndrome • Also known as allergic granulomatosis and angiitis • 1-3 / 1 000 000 • Histology similar to WG, but with eosinophillic infiltrates of the vessel walls • Prodromal period for years with allergic rhinitis, nasal polyposis and late-onset asthma • Triad of skin lesions, asymmetric mononeuritis multiplex and eosinophillia on a background of resistant asthma • Necrotizing GN • Mesenteric vascultitis • cANCA or pANCA

  23. Anca (-)

  24. Henlochshönleinpurpura • Characterized by deposition of IgA-containing immune complexes • Children and young adults • Purpura over the buttocks and lower legs, abdominal symptoms, arthritis following an URTI • GN can occur up to 4/52 after initial symptoms • Biopsy shows IgA deposition on IF • Generally good prognosis but adult presentation, hypertension, renal failure, significant proteinuria can progress to ESRF

  25. Essential cryglobulinemicvasculitis • Characterized by the presence of cryoglobulins • Mix of complement and immunoglobulins, that precipitate in the cold • Type 2 (hep C) and 3 ass with vasculitis • Palpable purpura, athralgia, Raynaud’s phenomena, neuropathy • Immune complexes are deposited in the vessel walls

  26. Hypersensitivity vasculitis • Some authors use this term to include HSP, mixed cryoglobulinemia, allergic vasculitis and serum sickness • Most properly used to refer to vasculitis occurring as a reaction to a known or suspected substance such as a drug. • Major finding is palpable purpura / petechiae – leucocytoclasticvasculitis on biopsy

  27. Vasculitis secondary to connective tissue disorder • SLE, RA, relapsing polychondritis, Bechet’s disease • Organ involvement is determined by the underlying disease

  28. Vascultitis secondary to viral infections • Hepatitis B, C • HIV, CMV, EBV, Parvo B19 • Clinical presentation can be similar to polyarteritisnodosa or microscopic poylangiitis • Even it is immune complex mediated, it must be distinguished form non-viral associated vasculitides, since the treatment is an anti-viral and not an anti-inflammatory regimen

  29. The presence of a vasculitic disorder should be considered in any patient with an unexplained systemic illness • Patients often present with non-specific symptoms • However, there are a few clinical scenarios where a vascultic disorder should be looked for… - palpable purpura - pulmonary infiltrates and microscopic hematuria - chronic inflammatory sinusitus - mononeuritis multiplex - unexplained ischaemic events - glomerulonephritis

  30. General Management of small vessel vasculitides • Primary - immunosuppressive therapy: steroids cyclophosphamide - Bactrim - plasma exchange in severe cases • Secondary - treat the underlying cause - antivirals - immunosuppression with connective tissue diseases - stop exposure to possible causative drugs

  31. Back to our patient… • Glomerulonephritis with renal failure • cANCA • Asymptomatic “ emphysema” diagnosis, myalgia and arthalgia • No ENT symptoms • No resistant asthma • No eosinophillia • No skin involvement • No drug exposure • Renal biopsy: necrotizing GN few crescents no granulomata or eosinophillic infiltrates

  32. Differential includes • Renal limited vascultitis / ANCA glomerulnephritis • Microscopic polyangiitis

  33. Management • Started on prednisone 1mg/kg/day cyclophosphamide 2mg/kg/day bactrim ca, titralac, vit D • Follow-up in 10/7 for review

  34. Thank you

More Related